Shareholdings
Concept |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shareholdings | ||||||||||||||||||
Reporting company | ||||||||||||||||||
Details of specified investment shares held for purposes other than pure investment | ||||||||||||||||||
Issue |
三井住友トラストグループ㈱
|
㈱三菱UFJフィナンシャル・グループ
|
㈱めぶきフィナンシャルグループ
|
みずほリース㈱
|
科研製薬㈱
|
㈱テクノ菱和
|
㈱みずほフィナンシャルグループ
|
参天製薬㈱
|
丸全昭和運輸㈱
|
— | — | — | — | — | — | — | — | — |
Number of shares |
xbrli:shares
|
259,700
xbrli:shares
|
63,180
xbrli:shares
|
665,000
xbrli:shares
|
502,500
xbrli:shares
|
49,170
xbrli:shares
|
24,040
xbrli:shares
|
1,130,000
xbrli:shares
|
121,400
xbrli:shares
|
49,170
xbrli:shares
|
121,400
xbrli:shares
|
502,500
xbrli:shares
|
1,130,000
xbrli:shares
|
24,040
xbrli:shares
|
63,180
xbrli:shares
|
3,720
xbrli:shares
|
259,700
xbrli:shares
|
133,000
xbrli:shares
|
Carrying amount |
JPY
|
522,000,000
JPY
|
45,000,000
JPY
|
693,000,000
JPY
|
2,251,000,000
JPY
|
129,000,000
JPY
|
97,000,000
JPY
|
1,602,000,000
JPY
|
729,000,000
JPY
|
99,000,000
JPY
|
568,000,000
JPY
|
1,738,000,000
JPY
|
1,736,000,000
JPY
|
73,000,000
JPY
|
32,000,000
JPY
|
12,000,000
JPY
|
404,000,000
JPY
|
772,000,000
JPY
|
Purpose of shareholding, overview of business alliance, quantitative effects of shareholding and reason for increase in number of shares |
財務面での取引関係を強化するため
|
財務面での取引関係を強化するため
|
財務面での取引関係を強化するため
|
財務面での取引関係を強化するため
|
医薬品事業の販売委託先として関係を強化するため
|
当社の設備調達における取引関係等を円滑にするため
|
財務面での取引関係を強化するため
|
医薬品事業の販売委託先として関係を強化するため
|
当社製品の物流をより円滑化するため
|
— | — | — | — | — | — | — | — | — |
Whether issuer of aforementioned shares holds reporting company's shares |
無
|
無
|
無
|
有
|
有
|
有
|
無
|
有
|
有
|
— | — | — | — | — | — | — | — | — |